ES8707447A1 - Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina. - Google Patents

Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.

Info

Publication number
ES8707447A1
ES8707447A1 ES545368A ES545368A ES8707447A1 ES 8707447 A1 ES8707447 A1 ES 8707447A1 ES 545368 A ES545368 A ES 545368A ES 545368 A ES545368 A ES 545368A ES 8707447 A1 ES8707447 A1 ES 8707447A1
Authority
ES
Spain
Prior art keywords
dimetoxiquinazoline
furoil
mino
piperazin
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545368A
Other languages
English (en)
Spanish (es)
Other versions
ES545368A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES545368A0 publication Critical patent/ES545368A0/es
Publication of ES8707447A1 publication Critical patent/ES8707447A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
ES545368A 1976-03-01 1977-02-28 Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina. Expired ES8707447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (2)

Publication Number Publication Date
ES545368A0 ES545368A0 (es) 1978-06-01
ES8707447A1 true ES8707447A1 (es) 1987-08-16

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545368A Expired ES8707447A1 (es) 1976-03-01 1977-02-28 Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.

Country Status (32)

Country Link
US (1) US4092315A (2)
JP (1) JPS604188B2 (2)
AR (1) AR210937A1 (2)
AU (1) AU506937B2 (2)
BE (1) BE851878A (2)
BG (1) BG29724A3 (2)
CA (1) CA1068269A (2)
CH (1) CH618436A5 (2)
CS (1) CS191332B2 (2)
DD (1) DD129652A5 (2)
DE (1) DE2708192C3 (2)
DK (1) DK145858C (2)
ES (1) ES8707447A1 (2)
FI (1) FI62082C (2)
FR (1) FR2372828A1 (2)
GB (1) GB1538713A (2)
HK (1) HK30881A (2)
HU (1) HU173641B (2)
IE (1) IE44522B1 (2)
IL (1) IL51481A (2)
LU (1) LU76868A1 (2)
MY (1) MY8100271A (2)
NL (1) NL169591C (2)
NO (1) NO146499C (2)
NZ (1) NZ183450A (2)
PL (1) PL105559B1 (2)
PT (1) PT66227B (2)
RO (1) RO73095A (2)
SE (1) SE423234B (2)
SU (1) SU644387A3 (2)
YU (1) YU41294B (2)
ZA (1) ZA77918B (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
DE59611417D1 (de) * 1996-12-20 2007-03-29 Heumann Pharma Gmbh & Co Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
CA2993152C (en) 2014-07-21 2022-12-13 Keir Manufacturing, Inc. Aerodynamic flyer bow

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines

Also Published As

Publication number Publication date
CA1068269A (en) 1979-12-18
CH618436A5 (2) 1980-07-31
YU49977A (en) 1983-12-31
NL169591C (nl) 1982-08-02
IE44522B1 (en) 1981-12-30
NZ183450A (en) 1979-03-16
US4092315A (en) 1978-05-30
DD129652A5 (de) 1978-02-01
JPS604188B2 (ja) 1985-02-01
JPS52105206A (en) 1977-09-03
IL51481A0 (en) 1977-04-29
ES545368A0 (es) 1978-06-01
SU644387A3 (ru) 1979-01-25
FI62082B (fi) 1982-07-30
HU173641B (en) 1979-07-28
AR210937A1 (es) 1977-09-30
HK30881A (en) 1981-07-10
SE423234B (sv) 1982-04-26
DK145858C (da) 1983-09-12
MY8100271A (en) 1981-12-31
YU41294B (en) 1987-02-28
AU2244377A (en) 1978-11-23
PT66227B (en) 1978-07-14
RO73095A (ro) 1981-06-26
DK145858B (da) 1983-03-21
DK86877A (da) 1977-09-02
DE2708192B2 (de) 1979-08-02
NO770674L (no) 1977-09-02
DE2708192C3 (de) 1980-05-08
ZA77918B (en) 1977-12-28
IE44522L (en) 1977-09-01
IL51481A (en) 1980-09-16
NO146499B (no) 1982-07-05
FI62082C (fi) 1982-11-10
PL105559B1 (pl) 1979-10-31
CS191332B2 (en) 1979-06-29
BE851878A (fr) 1977-08-29
FR2372828B1 (2) 1980-02-01
FI770634A7 (2) 1977-09-02
PT66227A (en) 1977-03-01
NL169591B (nl) 1982-03-01
LU76868A1 (2) 1977-09-21
GB1538713A (en) 1979-01-24
BG29724A3 (bg) 1981-01-15
NL7702123A (nl) 1977-09-05
DE2708192A1 (de) 1977-09-08
PL196354A1 (pl) 1978-02-27
NO146499C (no) 1982-10-13
AU506937B2 (en) 1980-01-31
SE7701624L (sv) 1977-09-02
FR2372828A1 (fr) 1978-06-30

Similar Documents

Publication Publication Date Title
ES8707447A1 (es) Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.
GB1067577A (en) The production of paper-like structures from flexifilament sheets
FR63781E (fr) Procédé de fabrication en continu d'articles creux en matière thermoplastique
CH309924A (fr) Procédé pour la fabrication d'articles poreux sous forme de feuilles et article obtenu par ce procédé.
FR1050942A (fr) Procédé de production de solutions d'élastomères de la série des polyesters
CH285783A (fr) Procédé pour la fabrication de feuilles ou bandes en matière plastique armée.
FR1472509A (fr) Procédé de production de plaques, de bandes, de feuilles ou de pellicules en matière plastique expansée
FR1044871A (fr) Procédé pour la fabrication de sacs ou sachets étanches en matière soudable telle que matière plastique, feuille d'aluminium, etc.
AT256448B (de) Strangpresse zum Herstellen gerippter Profile aus thermoplastischem Kunststoff
FR1197720A (fr) Procédé de fabrication de polymères linéaires synthétiques, tels que les téréphtalates de polyméthylène fortement polymères
AT310370B (de) Vorrichtung zur kontinuierlichen Herstellung von Dochten, Gespinsten oder Vliesen aus Fasern aus thermoplastischem Material
FR1288327A (fr) Procédé et appareil pour l'application continue d'une couche de matière thermoplastique sur une face d'une bande en métal, produits textiles résistant à la chaleur, et similaires
FR63748E (fr) Procédé pour la fabrication de feuilles en matière plastique
BR7102637D0 (pt) Um processo para a producao de um polimero capaz de ser polimerizado ulteriormente para formar materiais polimericos duros rigidos
ES173575A1 (es) UN PROCEDIMIENTO DE PRODUCIR POLiMEROS DE ÉTER Y VINIL-ISOPROPiLICO, ANáLOGOS AL CAUCHO Y DE FORMA ESTABLE
FR1519450A (fr) Procédé et équipement pour la fabrication de produits en feuille, notamment en papier et en matière plastique
ES373155A1 (es) Un procedimiento para la fabricacion de una banda de este- rilla elastica.
FR1203872A (fr) Procédé et machine pour la production en continu de laminés plans, ondulés ou à relief quelconque en matière plastique renforcée
ES268296A1 (es) Un procedimiento para preparar papel-sintetico a base de poliolefinas cristalinas
FR1041419A (fr) Procédé de soudure des feuilles de matière plastique
CH530858A (de) Verfahren zur Herstellung von beidseitig gerippten Kunststoffbahnen und nach dem Verfahren hergestellte Kunststoffbahn aus Rippenfolie
GB518345A (en) Improvements in and relating to pleated blinds
FR1154650A (fr) Procédé de production d'une nouvelle matière utilisable comme diélectrique
FR896069A (fr) Procédé de fabrication en deux phases de filaments, fils, petites bandes et produits analogues, à partir de composés polymères du vinyle, sensibles à la chaleur
FR1009537A (fr) Matière plastique utilisable comme couche protectrice pour le remplissage de joints, etc.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001